scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1019740591 |
P356 | DOI | 10.1007/BF02699936 |
P953 | full work available at URL | http://link.springer.com/article/10.1007/BF02699936/fulltext.html |
http://link.springer.com/content/pdf/10.1007/BF02699936 | ||
http://link.springer.com/content/pdf/10.1007/BF02699936.pdf | ||
P698 | PubMed publication ID | 12749705 |
P2093 | author name string | Akira Matsumura | |
Teruyoshi Kageji | |||
Hiroaki Kumada | |||
Yoshinobu Nakagawa | |||
Toru Kobayashi | |||
Shinichi Uyama | |||
Kyonghon Pooh | |||
P2860 | cites work | No Shinkei Geka | Q27712275 |
Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. | Q32157803 | ||
Neutron capture therapy with boron in the treatment of glioblastoma multiforme. | Q34234053 | ||
Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study | Q34239497 | ||
The possible use of neutron-capturing isotopes such as boron 10 in the treatment of neoplasms. II. Computation of the radiation energies and estimates of effects in normal and neoplastic brain | Q35191188 | ||
Glioblastoma multiforme: the terminator | Q36101892 | ||
The yield of DNA double-strand breaks produced intracellularly by ionizing radiation: a review | Q37589481 | ||
Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications | Q39495167 | ||
Chemotherapy of brain tumors: physiological and pharmacokinetic considerations | Q39728910 | ||
Relative biological effectiveness of fast neutrons for effects on normal tissues | Q39954937 | ||
Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain: a cautionary note | Q40932209 | ||
Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage | Q41015308 | ||
Survival of patients with glioblastoma multiforme treated by intraoperative high-activity cobalt 60 endocurietherapy | Q44499853 | ||
Neon heavy charged particle radiotherapy of glioblastoma of the brain | Q46109943 | ||
The effect of geometry on capillary wall dose for boron neutron capture therapy | Q46799499 | ||
A method for calculating the absorbed dose near interface from 10B(n, alpha)7Li reaction | Q48478996 | ||
Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results | Q48719601 | ||
Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors | Q48719616 | ||
Boron neutron capture therapy. Clinical brain tumor studies | Q48719628 | ||
Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron Compounds | Q51210966 | ||
The possible use of neutron-capturing isotopes such as boron 10 in the treatment of neoplasms. I. Intracranial tumors. | Q51352818 | ||
The Monte Carlo simulation of the biological effect of the 10B(n, alpha)7Li reaction in cells and tissue and its implication for boron neutron capture therapy. | Q52593422 | ||
Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. | Q54249652 | ||
[Patterns of recurrence in malignant gliomas after brachytherapy] | Q55482044 | ||
Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium | Q72837468 | ||
Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma | Q74410459 | ||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neurology | Q83042 |
oncology | Q162555 | ||
P304 | page(s) | 87-99 | |
P577 | publication date | 2003-03-01 | |
P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
P1476 | title | Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams | |
Clinical review of the japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams | |||
P478 | volume | 62 |
Q35128580 | A critical assessment of boron neutron capture therapy: an overview |
Q60356185 | A realistic appraisal of boron neutron capture therapy as a cancer treatment modality |
Q37630245 | Boron Neutron Capture Therapy - A Literature Review |
Q35551698 | Boron Neutron Capture Therapy: Cellular Targeting of High Linear Energy Transfer Radiation |
Q89141802 | Boron delivery agents for neutron capture therapy of cancer |
Q37058434 | Boron neutron capture therapy for glioblastoma: is it worth pursuing? |
Q64105428 | Boron-incorporating hemagglutinating virus of Japan envelope (HVJ-E) nanomaterial in boron neutron capture therapy |
Q48461351 | Characterization of moderator assembly dimension for accelerator boron neutron capture therapy of brain tumors using 7Li(p, n) neutrons at proton energy of 2.5 MeV. |
Q34286573 | Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors |
Q34369684 | Dendrimers in medical nanotechnology |
Q55472136 | Histopathological findings in autopsied glioblastoma patients treated by mixed neutron beam BNCT. |
Q47328648 | Physics of epi-thermal boron neutron capture therapy (epi-thermal BNCT). |
Q92936157 | Synthesis and Evaluation of Thermoresponsive Boron-Containing Poly(N-isopropylacrylamide) Diblock Copolymers for Self-Assembling Nanomicellar Boron Carriers |
Q36629332 | Synthesis and in vitro properties of trimethylamine- and phosphonate-substituted carboranylporphyrins for application in BNCT |
Q40379759 | The boron-neutron capture agent beta-D-5-o-carboranyl-2'-deoxyuridine accumulates preferentially in dividing brain tumor cells |
Search more.